262 related articles for article (PubMed ID: 26846787)
21. C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.
Sethi S; Fervenza FC; Zhang Y; Zand L; Vrana JA; Nasr SH; Theis JD; Dogan A; Smith RJ
Kidney Int; 2012 Aug; 82(4):465-73. PubMed ID: 22673887
[TBL] [Abstract][Full Text] [Related]
22. Hypocomplementemia and membranoproliferative glomeruloneophritis in children.
Iitaka K; Nakamura S; Moriya S; Koshino H; Iwanami N; Sakai T; Motoyama O
Clin Exp Nephrol; 2005 Mar; 9(1):31-3. PubMed ID: 15830270
[TBL] [Abstract][Full Text] [Related]
23. Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification.
Sethi S; Fervenza FC
Semin Nephrol; 2011 Jul; 31(4):341-8. PubMed ID: 21839367
[TBL] [Abstract][Full Text] [Related]
24. Long-term clinical and morphological evaluation of primary membranoproliferative glomerulonephritis.
Wu MJ; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Hsu YH; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):34-41. PubMed ID: 8820034
[TBL] [Abstract][Full Text] [Related]
25. C3 glomerulopathy.
Servais A; Noël LH; Frémeaux-Bacchi V; Lesavre P
Contrib Nephrol; 2013; 181():185-93. PubMed ID: 23689580
[TBL] [Abstract][Full Text] [Related]
26. Histopathology of MPGN and C3 glomerulopathies.
Cook HT; Pickering MC
Nat Rev Nephrol; 2015 Jan; 11(1):14-22. PubMed ID: 25447133
[TBL] [Abstract][Full Text] [Related]
27. FHR-5 Serum Levels and
Garam N; Cserhalmi M; Prohászka Z; Szilágyi Á; Veszeli N; Szabó E; Uzonyi B; Iliás A; Aigner C; Schmidt A; Gaggl M; Sunder-Plassmann G; Bajcsi D; Brunner J; Dumfarth A; Cejka D; Flaschberger S; Flögelova H; Haris Á; Hartmann Á; Heilos A; Mueller T; Rusai K; Arbeiter K; Hofer J; Jakab D; Sinkó M; Szigeti E; Bereczki C; Janko V; Kelen K; Reusz GS; Szabó AJ; Klenk N; Kóbor K; Kojc N; Knechtelsdorfer M; Laganovic M; Lungu AC; Meglic A; Rus R; Kersnik Levart T; Macioniene E; Miglinas M; Pawłowska A; Stompór T; Podracka L; Rudnicki M; Mayer G; Rysava R; Reiterova J; Saraga M; Seeman T; Zieg J; Sládková E; Stajic N; Szabó T; Capitanescu A; Stancu S; Tisljar M; Galesic K; Tislér A; Vainumäe I; Windpessl M; Zaoral T; Zlatanova G; Józsi M; Csuka D
Front Immunol; 2021; 12():720183. PubMed ID: 34566977
[TBL] [Abstract][Full Text] [Related]
28. C3 glomerulonephritis associated with ANCA positivity: a case report.
Li L; Liu LQ; Yang YY; Hu ZX
BMC Nephrol; 2021 Apr; 22(1):143. PubMed ID: 33882866
[TBL] [Abstract][Full Text] [Related]
29. Membranoproliferative glomerulonephritis in Russian population.
Dobronravov VA; Smirnov AV
Ter Arkh; 2018 Dec; 90(12):39-47. PubMed ID: 30701832
[TBL] [Abstract][Full Text] [Related]
30. Membranoproliferative glomerulonephritis and circulating cryoglobulins.
Hiramatsu R; Hoshino J; Suwabe T; Sumida K; Hasegawa E; Yamanouchi M; Hayami N; Sawa N; Takaichi K; Ohashi K; Fujii T; Ubara Y
Clin Exp Nephrol; 2014 Feb; 18(1):88-94. PubMed ID: 23722669
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis and treatment of glomerular diseases with a membranoproliferative glomerulonephritis (MPGN) pattern of injury].
Rudnicki M; Windpessl M; Eller K; Odler B; Gauckler P; Neumann I; Zitt E; Regele H; Kronbichler A; Lhotta K; Säemann MD
Wien Klin Wochenschr; 2023 Aug; 135(Suppl 5):688-695. PubMed ID: 37728653
[TBL] [Abstract][Full Text] [Related]
32. [Clinicopathological survey of persistent hypocomplementemic glomerulonephritis in children; correlation of DPGN and MPGN type I].
Hattori S; Hiramatsu M; Ushijima T; Karashima S; Furuse A; Matsuda I; Takebayashi S
Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):773-81. PubMed ID: 1479716
[TBL] [Abstract][Full Text] [Related]
33. C3 glomerulopathy: clinicopathologic features and predictors of outcome.
Medjeral-Thomas NR; O'Shaughnessy MM; O'Regan JA; Traynor C; Flanagan M; Wong L; Teoh CW; Awan A; Waldron M; Cairns T; O'Kelly P; Dorman AM; Pickering MC; Conlon PJ; Cook HT
Clin J Am Soc Nephrol; 2014 Jan; 9(1):46-53. PubMed ID: 24178974
[TBL] [Abstract][Full Text] [Related]
34. [Immune complexes and C3 and C4 of the complement in urine of patients with glomerulonephritis].
Kacprzyk F; Chrzanowski W
Pol Arch Med Wewn; 1996 Sep; 96(3):215-23. PubMed ID: 9122012
[TBL] [Abstract][Full Text] [Related]
35. Decreasing hypocomplementemia and membranoproliferative glomerulonephritis in Japan.
Iitaka K; Saka T; Yagisawa K; Aoki Y
Pediatr Nephrol; 2000 Aug; 14(8-9):794-6. PubMed ID: 10955929
[TBL] [Abstract][Full Text] [Related]
36. Morphofunctional Effects of C5 Convertase Blockade in Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Report of Two Cases with Evidence of Terminal Complement Activation.
Carrara C; Podestà MA; Abbate M; Rizzo P; Piras R; Alberti M; Daina E; Ruggenenti P; Remuzzi G;
Nephron; 2020; 144(4):195-203. PubMed ID: 32050203
[TBL] [Abstract][Full Text] [Related]
37. C3 glomerulonephritis and autoimmune disease: more than a fortuitous association?
Alexander MP; Fervenza FC; De Vriese AS; Smith RJH; Nasr SH; Cornell LD; Herrera Hernandez LP; Zhang Y; Sethi S
J Nephrol; 2016 Apr; 29(2):203-209. PubMed ID: 26187133
[TBL] [Abstract][Full Text] [Related]
38. A patient with membranoproliferative glomerulonephritis diagnosed by the third biopsy via endocapillary proliferative glomerulonephritis and focal membranoproliferative glomerulonephritis.
Kano K; Nishikura K; Kojima M; Yamada Y; Arisaka O; Tomita S; Shimotsuji T; Fujikawa Y; Inafuku S; Imakita M; Ueda Y
Clin Exp Nephrol; 2003 Jun; 7(2):157-62. PubMed ID: 14586735
[TBL] [Abstract][Full Text] [Related]
39. [Familial membranoproliferative glomerulonephritis].
Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
[TBL] [Abstract][Full Text] [Related]
40. Manifestations of Complement-Mediated and Immune Complex-Mediated Membranoproliferative Glomerulonephritis: A Comparative Consecutive Series.
Dalvin LA; Fervenza FC; Sethi S; Pulido JS
Ophthalmology; 2016 Jul; 123(7):1588-94. PubMed ID: 26996341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]